A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer

Clinical trial NCT06111274 · RECRUITING

Trial details

NCT number: NCT06111274
Sponsor: Abbisko Therapeutics Co, Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Cancer

Start date: 2023-10-17
Primary completion: 2025-12-30
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.